Global venture capital firm with a focus on early and growth-stage technology companies.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Orange Quantum Systems | 2025 | Seed | $13.8M | Delft |
| Scope Biosciences | 2025 | Seed | $1.2M | Wageningen |
| PFx Biotech | 2025 | Grant | $2.9M | Porto |
| Lumoview Building Analytics | 2025 | Seed | $3.4M | Cologne |
| TILT Biotherapeutics | 2025 | Series B | $25.3M | Helsinki |
| Cerabyte | 2025 | Corporate Round | Undisclosed | Munich |
| Catalyxx | 2025 | Debt Financing | $3.4M | Chesterfield |
| Esencia Foods | 2025 | Seed | $1.1M | Berlin |
| Nuada | 2025 | Grant | $2.8M | Belfast |
| Solmeyea | 2025 | Grant | $3.3M | Pallíni |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 226 | Orange Quantum Systems | Seed | $13.8M | Delft, The Netherlands |
| 227 | Scope Biosciences | Seed | $1.2M | Wageningen, The Netherlands |
| 228 | PFx Biotech | Grant | $2.9M | Porto, Portugal |
| 229 | Lumoview Building Analytics | Seed | $3.4M | Cologne, Germany |
| 230 | TILT Biotherapeutics | Series B | $25.3M | Helsinki, Finland |
| 231 | Cerabyte | Corporate Round | Undisclosed | Munich, Germany |
| 232 | Catalyxx | Debt Financing | $3.4M | Chesterfield, United States |
| 233 | Esencia Foods | Seed | $1.1M | Berlin, Germany |
| 234 | Nuada | Grant | $2.8M | Belfast, United Kingdom |
| 235 | Solmeyea | Grant | $3.3M | Pallíni, Greece |
Orange Quantum Systems offers quantum software, diagnosis, and system services.
Scope Biosciences is a on-site development platform technology specializing in the development of molecular diagnostics using CRISPR-Cas.
PFx Biotech is a disruptive startup developing human milk proteins as alternative proteins by precision fermentation.
Lumoview digitizes buildings in 2 seconds per room and empowers owners to improve their buildings and reduce CO2 emissions.
TILT Biotherapeutics Ltd is the leading company globally working in the area of enabling tumor.
Cerabyte develops a ceramic-based data storage technology, offering a unique solution for data preservation.
Catalyxx Inc focuses on sustainable chemical processes using thermo-chemical catalytic technology.
Esencia Foods is a food and beverages company that makes vegan meat from mycelium solid state fermentation.
We help hard-to-abate industries to decarbonise by vacuuming CO2 out of flue gas
Solmeyea produces single-cell proteins from CO2 for food applications, aiming at CO2 circularity and addressing climate issues.
Zero Point Motion develops inertial sensors to enable precision positioning and navigation.
Strolll is a digital health startup developing solutions for the mobility of people living with neurological disorders.
Nurami Medical develops smart nano-fiber technologies for surgical use.
FluIDect develops real-time, on-site pathogen detection devices, bringing lab analytics to production lines for real-time results.
Iktos is a deep learning technology platform focused on new drug design and discovery.
MyoPax creates advanced regenerative stem cell therapies to combat the devasting effects of muscle illnesses.
SemiQon develops semiconductor technologies that focus on energy-efficient chips for quantum computing and high-performance applications.
Medical device for clot retrival
Neurescue, a medical device manufacturer based in Denmark, is developing cardiovascular devices to help emergency patients.
Invitris is a biotech company that develops protein-based drugs.
CarbonX develops and supplies new materials to design the next generation of materials.
Veridi Technologies creates technology that allows farmers to detect diseases at an early stage.
StarTric develops a transcatheter tricuspid valve repair system to treat tricuspid heart valves.
MOF Technologies is an environmental service firm that provides point-source carbon capture solutions for decarbonizing heavy industries.
MetisMotion is innovative technology enables ultra-light and dynamic actuators.
EIC Accelerator has invested in 315 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
EIC Accelerator's top investment sectors include Biotechnology, Health Care, Medical Device, Information Technology, Chemical. The firm invests across 52 different industry categories.
Among tracked funding rounds, Nurami Medical received $30.0M in a Undisclosed round. EIC Accelerator's total known invested capital is $1.4B.
EIC Accelerator's average investment size is $5.0M across its portfolio of 315 companies.
Recent EIC Accelerator portfolio additions include Orange Quantum Systems, Scope Biosciences, PFx Biotech, Lumoview Building Analytics, TILT Biotherapeutics. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors